 <h1>Orvaten Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>midodrine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about midodrine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Orvaten.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to midodrine: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Can cause marked elevation of supine blood pressure and should be used only in patients whose lives are considerably impaired despite standard clinical care. Clinical benefits of midodrine hydrochloride tablets, principally improved ability to carry out activities of daily living, have not been verified.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, midodrine (the active ingredient contained in Orvaten) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking midodrine:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>cardiac awareness</li>
<li>headache</li>
<li>pounding in the ears</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Fainting</li>
<li>increased dizziness</li>
<li>slow pulse</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of midodrine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Burning, itching, or prickling of the scalp</li>
<li>chills</li>
<li>goosebumps</li>
<li>urinary frequency, retention, or urgency</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety or nervousness</li>
<li>confusion</li>
<li>dry mouth</li>
<li>flushing</li>
<li>headache or feeling of pressure in the head</li>
<li>skin rash</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Backache</li>
<li>canker sores</li>
<li>dizziness</li>
<li>drowsiness</li>
<li>dry skin</li>
<li>leg cramps</li>
<li>pain or sensitivity of the skin to touch</li>
<li>stomach problems such as gas, heartburn, or nausea</li>
<li>trouble seeing</li>
<li>trouble with sleeping</li>
<li>weakness</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to midodrine: oral tablet</i></p><h3>General</h3><p>The most common adverse reactions were paresthesia (includes hyperesthesia and scalp paresthesia), piloerection, dysuria (includes dysuria, increased urinary frequency, impaired urination, urinary retention, and urinary urgency), pruritus (includes scalp pruritus), and supine hypertension.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Supine hypertension, flushing</p>
<p><b>Uncommon</b> (0.1% to 1%): Reflex bradycardia</p>
<p><b>Rare</b> (less than 0.1%): Tachycardia, palpitations</p>
<p><b>Frequency not reported</b>: Vasodilation/flushing face<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Paresthesia (18.3%)</p>
<p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Frequency not reported</b>: Feeling of pressure/fullness in the head, dizziness, somnolence<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Piloerection (13.4%), pruritus (12.2%)</p>
<p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Frequency not reported</b>: Skin hyperesthesia, erythema multiforme, dry skin<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Dysuria (13.4%)</p>
<p><b>Frequency not reported</b>: Impaired urination<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, dyspepsia, stomatitis</p>
<p><b>Frequency not reported</b>: Dry mouth, canker sore, pyrosis, gastrointestinal distress, flatulence, abdominal pain, vomiting, diarrhea<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Chills, pain</p>
<p><b>Frequency not reported</b>: Asthenia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Sleep disorders, insomnia, restlessness, excitability, irritability</p>
<p><b>Frequency not reported</b>: Confusion/thinking abnormality, nervousness/anxiety<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Abnormal hepatic function, raised liver enzymes<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Backache, leg cramps<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Visual field defect<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. ProAmatine (midodrine)." Roberts Pharmaceutical Corporation, Eatontown, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Orvaten (midodrine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>1 Review</li>
<li>Drug class: miscellaneous cardiovascular agents</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>ProAmatine</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Dysautonomia</li>
<li>Hypotension</li>
<li>Postural Orthostatic Tachycardia Syndrome</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to midodrine: oral tablet</i></p><h3>General</h3><p>The most common adverse reactions were paresthesia (includes hyperesthesia and scalp paresthesia), piloerection, dysuria (includes dysuria, increased urinary frequency, impaired urination, urinary retention, and urinary urgency), pruritus (includes scalp pruritus), and supine hypertension.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Supine hypertension, flushing</p><p><b>Uncommon</b> (0.1% to 1%): Reflex bradycardia</p><p><b>Rare</b> (less than 0.1%): Tachycardia, palpitations</p><p><b>Frequency not reported</b>: Vasodilation/flushing face<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Paresthesia (18.3%)</p><p><b>Common</b> (1% to 10%): Headache</p><p><b>Frequency not reported</b>: Feeling of pressure/fullness in the head, dizziness, somnolence<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Piloerection (13.4%), pruritus (12.2%)</p><p><b>Common</b> (1% to 10%): Rash</p><p><b>Frequency not reported</b>: Skin hyperesthesia, erythema multiforme, dry skin<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Dysuria (13.4%)</p><p><b>Frequency not reported</b>: Impaired urination<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, dyspepsia, stomatitis</p><p><b>Frequency not reported</b>: Dry mouth, canker sore, pyrosis, gastrointestinal distress, flatulence, abdominal pain, vomiting, diarrhea<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Chills, pain</p><p><b>Frequency not reported</b>: Asthenia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Sleep disorders, insomnia, restlessness, excitability, irritability</p><p><b>Frequency not reported</b>: Confusion/thinking abnormality, nervousness/anxiety<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Abnormal hepatic function, raised liver enzymes<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Backache, leg cramps<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Visual field defect<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. ProAmatine (midodrine)." Roberts Pharmaceutical Corporation, Eatontown, NJ. </p><h2>More about Orvaten (midodrine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>1 Review</li>
<li>Drug class: miscellaneous cardiovascular agents</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Dysautonomia</li>
<li>Hypotension</li>
<li>Postural Orthostatic Tachycardia Syndrome</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>